Dermapharm is plotting a change of tack at French subsidiary Arkopharma to reignite growth in the face of increased competition in Europe’s dietary supplements market.
Reporting lower revenues at Arkopharma for 2024, Dermapharm said it had set in motion a realignment of the business model so that pharmacists become “more closely involved in marketing as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?